5-10
2026
影响因子区间
—
平台估算
24%
2025
中国作者发文占比
USD 3,290
收费
期刊简介:This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment.We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
【译文】本期刊旨在回顾最近发表的治疗领域的重要进展。通过提供国际专家清晰、深入、平衡的贡献,该期刊旨在促进全球癌症治疗方法的实施。我们通过任命国际权威人士担任关键领域的部门编辑,如内分泌肿瘤、淋巴瘤、神经肿瘤、乳腺癌、头颈癌、肺癌、皮肤癌、胃肠道癌和泌尿生殖区域,来实现这一目标。部门编辑随后选择主题,由主要专家撰写全面综述文章,强调新发展和最近发表的具有重大重要性的论文,并附有注释参考文献列表。我们还提供知名肿瘤学家的评论,国际编委会审查年度目录,建议其国家/地区的特别感兴趣的文章,并确保主题是当前的和包括新兴研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |